Synthesis and evaluation of paclitaxel C7 derivatives: Solution phase synthesis of combinatorial libraries

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 22, 1998, Pages 3181-3186

  Bhat, Laxminarayan ^a   Liu, Yanbin ^a   Victory, Sam F ^a   Himes, Richard H ^a   Georg, Gunda I ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTER; PACLITAXEL; PACLITAXEL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DEVICE; DRUG PURIFICATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; MICROTUBULE ASSEMBLY; MULTIDRUG RESISTANCE; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE EXTRACTION; STRUCTURE ACTIVITY RELATION;

EID: 0032542047     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00551-4     Document Type: Article

References (28)

1. 1. For recent monographs, see: (a) Taxol® Science and Applications; Suffines, M.; Ed.; CRC: Boca Raton, 1995.
2. (b) The Chemistry and Pharmacology of Taxol® and Its Derivatives; Farina, V., Ed.; Elsevier: Amsterdam, 1995.
3. (c) Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M. Eds.; ACS Symposium Series 583; American Chemical Society: Washington, DC, 1995.
4. 2. For recent reviews see: (a) Fecik, R. A.; Frank, K. E.; Gentry, E. J.; Menon, S. R.; Mitscher, L. A. Telikepalli, H. Med. Res. Rev. 1998, 3, 149.
5. (b) Combinatorial Chemistry: Synthesis and Application; Wilson, S. R.; Czarnik, A. W., Eds.; Wiley: New York, 1997.
6. (c) Nefzi, A.; Ostresh, J. M.; Houghten; R. A. Chem. Rev. 1997, 97, 449.
7. (d) Balkenhohl, F.; von dem Bussche-Hunnefeld, C.; Lansky, A.; Zechel, C. Angew. Chem., Int. Ed. Engl. 1996, 35, 2288.
8. (e) Ellman, J. A. Acc. Chem. Res. 1996, 29, 132.
9. 3. Xiao, X.; Zhao, C.; Potash, H.; Nova, M. P. Angew. Chem., Int. Ed. Engl. 1997, 36, 780 and references cited therein
10. 4. (a) Hermkens, P. H. H.; Ottenheijm, H. C. T.; Rees, D. C. Tetrahedron 1997, 53, 6543.
11. (b) Hermkens, P. H. H.; Ottenheiijm, H. C. T.; Rees, D. C. Tetrahedron 1996, 52, 4527.
12. 5. Tetrahedron Symposia-in-Print number 70, Solution Phase Combinatorial Chemistry, Ed. Coffen, D. L. Tetrahedron 1998, 54, pp 3955-4150.
13. 6. Xiao, X.-Y.; Parandoosh, Z.; Nova, M. P. J. Org. Chem. 1997, 62, 6029.
14. 7. Boge, T. C.; Georg, G. I. The Medicinal Chemistry of β-Amino Acids: Paclitaxel as an Illustrative Example. In Enantioselective Synthesis of β-Amino Acids; Jurasti, E., Ed.; Wiley-VCH: New York, 1997; pp 1-43.
15. 8. Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Clowers, J. S.; Harriman, G. C. B.; Herperle, M.; Park, H. The Medicinal Chemistry of Taxol. In Taxol® Science and Applications; Suffness, M., Ed.; CRC: Boca Raton, FL, 1995; pp 317-375.
16. 9. (a) Takahasni, T.; Tsukamoto, H.; Yamada, H. Bioorg. Med. Chem. Lett. 1998, 8, 113.
17. (b) Vyas, D. M.; Ueda, Y.; Wong, H.; Matiskella, J. D.; Hauck, S.; Mikkilineni, A. B.; Farina, V.; Rose, W. C.; Casazza, A. M. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Eds.; ACS Symposium Series 583; American Chemical Society: Washington, DC, 1995; pp 124-137.
18. 10. (a) Georg, G. I.; Liu, Y.; Boge, T. C. Bioorg. Med. Chem. Lett. 1997, 7, 1829.
19. (b) Georg, G. I.; Boge, T. C.; Park, H. Bioorg. Med. Chem. Lett. 1995, 6, 615.
20. (c) Dasgupta, D.; Park, H.; Harriman, G. C. B.; Georg, G. I.; Himes, H. R. J. Med. Chem. 1994, 37, 2976.
21. 11. (a) Seelig, A. Eur. J. Biochem. 1998, 257, 252.
22. (b) Gottesman, M. M.; Pastan, I. Annu. Rev. Biochem. 1993, 62, 385.
23. (c) Ford, J. M.; Hait, W. N. Pharmacol Rev. 1990, 42, 155.
24. 12. Ojima, I.; Slater, J. C.; Michaud, E.; Kuduk, S. D.; Bounaud, P.-Y.; Vrignaud, P.; Bissery, M. C.; Veith, J. M.; Pera, P.; Bernacki, R. J. J. Med. Chem. 1996, 39, 3889.
25. 13. Georg, G. I.; Ali, S. M.; Boge, T. C.; Datta, A.; Falborg, L.; Park, H.; Mejillano, M.; Himes, R. H. Bioorg. Med. Chem. Lett. 1995, 5, 259.
26. 14. Other deprotection methods gave either complex reaction mixtures (TBAF) or products that were more difficult to purify (HF-pyridine).
27. 15. The yields refer to a two-step synthesis. The desilylation of compounds 3a-z to 4a-z proceeded in quantitative yields.
28. 16. For description of the tubulin assembly assay see: Ali, S. M.; Hoemann, M. Z.; Aube, J.; Mitscher, L. A Georg, G. I.; McCall, R.; Jayasinghe, L. R. J. Med. Chem. 1995, 38, 3821.